Ally Bridge Group’s Replimune Group REPL Stock Holding History

Ally Bridge Group’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-528,491	Closed	-$3.38M	–	35
2025 Q2	$4.91M	Buy	+528,491	New	+$4.61M	4.09%	8

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ally Bridge Group's REPL Position: Q3 2025 in Review

Ally Bridge Group sold out of Replimune Group (REPL) in Q3 2025, closing a stake of 528,491 shares — an estimated $3.38M sold.

Ally Bridge Group first reported a position in REPL in Q2 2025 and held it in 1 quarter. The position peaked at $4.91M in Q2 2025. 163 funds tracked by Wall St. Rank hold REPL as of Q3 2025.

Ally Bridge Group reported no remaining Replimune Group position as of Q3 2025 after selling out during the quarter.
Ally Bridge Group sold 528,491 Replimune Group shares in Q3 2025, an estimated $3.38M.
Ally Bridge Group first reported a position in Replimune Group in Q2 2025 and held it in 1 quarter.
Ally Bridge Group's Replimune Group position peaked at $4.91M in Q2 2025.
163 funds tracked by Wall St. Rank held Replimune Group as of Q3 2025.

Based on Ally Bridge Group's 13F filing for Q3 2025, filed 14 Nov 2025.